COWEN AND COMPANY, LLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$23,875,868
-13.4%
460,0360.0%1.67%
-26.9%
Q2 2023$27,583,758
+37.7%
460,036
+13.5%
2.29%
-2.8%
Q1 2023$20,031,802
-13.4%
405,1740.0%2.35%
-2.7%
Q4 2022$23,123,280
-51.3%
405,174
-59.9%
2.42%
-46.8%
Q3 2022$47,488,0001,011,6704.54%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$34,592,30327.53%
RTW INVESTMENTS, LP 6,029,633$361,536,7956.88%
Paradigm Biocapital Advisors LP 1,270,124$76,156,6355.88%
Rock Springs Capital Management LP 3,028,410$181,583,4644.32%
Logos Global Management LP 500,000$29,980,0004.08%
TANG CAPITAL MANAGEMENT LLC 405,600$24,319,7763.58%
GREAT POINT PARTNERS LLC 297,082$17,813,0373.49%
Eschler Asset Management LLP 34,000$2,038,6402.89%
COWEN AND COMPANY, LLC 460,036$27,583,7582.29%
HighVista Strategies LLC 44,094$2,643,8761.21%
View complete list of IMMUNOCORE HLDGS PLC shareholders